James Darecca

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. D'Arecca
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for James Darecca

Form 4 holding Chief Financial Officer

TherapeuticsMD, Inc.

Security class
Restricted Stock Units
Shares / value
434,333
Estimated value
$1,580,147
Report date
10 Aug 2021
Price
$3.64
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

TherapeuticsMD, Inc.

Security class
Common Stock
Shares / value
123,830
Estimated value
$277,255
Report date
12 Aug 2021
Price
$2.24
Ownership
Direct
Form 4 holding EVP, Chief Financial Officer

HAEMONETICS CORP

Security class
Non-qualified Stock Option (Right to Buy)
Shares / value
15,396
Estimated value
Report date
16 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by James Darecca

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .